Literature DB >> 26748444

Pathophysiology of pruritus in primary localized cutaneous amyloidosis.

H L Tey1,2, T Cao1, L A Nattkemper3, V W D Tan1, Z A D Pramono1, G Yosipovitch3.   

Abstract

BACKGROUND: Primary localized cutaneous amyloidosis (PLCA) is a chronic pruritic dermatosis prevalent among Southern Chinese and South American populations. Pruritus is frequently present and can be debilitating; its pathophysiology is largely unknown.
OBJECTIVES: To investigate if small-fibre neuropathy (SFN), which results in a reduction of intraepidermal nerve fibres (IENF) and abnormalities in quantitative thermal sensory testing (QST), is present in PLCA.
METHODS: Twenty Chinese patients (10 men) and 20 ethnicity-, sex- and age-matched controls underwent QST assessments. The patients' warm detection threshold (WDT) and heat pain threshold at the typical lesional sites were determined. Serum interleukin (IL)-31 levels were measured. Lesional biopsies were stained for IENF, IL-31 and its receptor's subunits [IL-31RA and oncostatin M receptor-β (OSMRβ)], and nerve growth factor (NGF) and its receptor [tropomyosin receptor kinase A (TrkA)], and were compared with normal skin obtained from archival paraffin-embedded specimens.
RESULTS: WDT was significantly higher in patients at all sites and correlated with itch scores (r = 0·59; P < 0·01). Patient biopsies revealed lower IENF counts (P < 0·01 using protein gene product 9.5, β3-tubulin and Neurofilament 200 stains) and increased epidermal expression of OSMRβ (P < 0·01) and IL-31RA (P < 0·01). Cutaneous IL-31, NGF and TrkA stains were not significantly increased in patients. Serum IL-31 was not significantly higher in patients.
CONCLUSIONS: SFN is present in PLCA. Pruritus in PLCA is likely associated with hypersensitivity of cutaneous nerve fibres, which may be related to an increased expression of epidermal IL-31 receptors. Targeting IL-31 receptors is therefore a potential therapeutic approach.
© 2016 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26748444     DOI: 10.1111/bjd.14391

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  Pruritus: From the Bench to the Bedside.

Authors:  Adam Reich; Laurent Misery; Kenji Takamori
Journal:  Biomed Res Int       Date:  2018-05-22       Impact factor: 3.411

Review 2.  Neuroimmune interactions in chronic itch of atopic dermatitis.

Authors:  G Yosipovitch; T Berger; M S Fassett
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-11-12       Impact factor: 6.166

Review 3.  Interleukin-31 as a Clinical Target for Pruritus Treatment.

Authors:  Kenji Kabashima; Hiroyuki Irie
Journal:  Front Med (Lausanne)       Date:  2021-02-12

4.  OSMRβ mutants enhance basal keratinocyte differentiation via inactivation of the STAT5/KLF7 axis in PLCA patients.

Authors:  Jun Liu; Junchen Chen; Yadan Zhong; Xiaoling Yu; Ping Lu; Jianqi Feng; Xin Zhang; Shufeng Ma; Chao Yang; Bin Yang; Zhili Rong
Journal:  Protein Cell       Date:  2021-01-27       Impact factor: 14.870

Review 5.  Advances in understanding itching and scratching: a new era of targeted treatments.

Authors:  Kristen M Sanders; Leigh A Nattkemper; Gil Yosipovitch
Journal:  F1000Res       Date:  2016-08-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.